Toxicité cardiaque du polidocanol : rapport d’un cas et revue de la littérature

Agence nationale d’accréditation et d’évaluation en santé. Traitement des varices des membres inférieurs. Paris; Anaes. Juin 2004. Lance, 1995, La sclérothérapie, 115 Hamel-Desnos, 2003, Evaluation of the efficacy of polidocanol in the form of foam compared with liquid form in sclerotherapy of the greater saphenous vein: initial results, Dermatol Surg, 29, 1170, 10.1111/j.1524-4725.2003.29398.x Frullini, 2002, Sclerosing foam in the treatment of varicose veins and telangiectases: history and analysis of safety and complications, Dermatol Surg, 28, 11, 10.1046/j.1524-4725.2002.01182.x Barrett, 2004, Microfoam ultrasound-guided sclerotherapy of varicose veins in 100 legs, Dermatol Surg, 30, 6, 10.1111/j.1524-4725.2004.30008.x Yamaki, 2004, Comparative study of duplex-guided foam sclerotherapy and duplex-guided liquid sclerotherapy for the treatment of superficial venous insufficiency, Dermatol Surg, 30, 718, 10.1111/j.1524-4725.2004.30202.x Alos, 2006, Efficacy and safety of sclerotherapy using polidocanol foam: a controlled clinical trial, Eur J Vasc Endovasc Surg, 31, 101, 10.1016/j.ejvs.2005.08.018 Jia, 2007, Systematic review of foam sclerotherapy for varicose veins, Br J Surg, 94, 925, 10.1002/bjs.5891 Guex, 2005, Immediate and midterm complications of sclerotherapy: report of a prospective multicenter registry of 12,173 sclerotherapy sessions, Dermatol Surg, 31, 123, 10.1111/j.1524-4725.2005.31030 Feied, 1994, Allergic reactions to polidocanol for vein sclerosis. Two case reports, J Dermatol Surg Oncol, 20, 466, 10.1111/j.1524-4725.1994.tb03218.x Butterworth, 1990, Molecular mechanisms of local anesthesia: a review, Anesthesiology, 72, 711, 10.1097/00000542-199004000-00022 Patlak, 1991, Molecular kinetics of voltage-dependent Na+ channels, Physiol Rev, 71, 1047, 10.1152/physrev.1991.71.4.1047 Courtney, 1988, Bupivacaine is an effective potassium channel blocker in heart, Biochem Biophys Acta, 939, 163, 10.1016/0005-2736(88)90058-2 Coyle, 1987, Bupivacaine and lidocaine blockade of calcium-mediated slow action potentials in guinea-pig ventricular muscle, J Pharmacol Exp Ther, 242, 1001 Strichartz GR, Berde CB. Anesthésiques locaux. In : Anesthésie, Miller RD ed. Médecine-Sciences Flammarion; Paris: 1996. pp. 489-521. Oexle, 1988, Effects of polidocanol as a constituent of a venous sclerosing agent on cardiac electrical activity. Studies on the isolated perfused heart and papillary muscle of the guinea pig and on the isolated sinus node of the rabbit, Arzneimittelforschung, 38, 1578 Azma, 2003, Does lidocaine provoke clinically significant vasospasm?, Acta Anaesthesiol Scand, 47, 1174, 10.1034/j.1399-6576.2003.00229.x Newton, 2007, Mechanisms influencing the vasoactive effects of lidocaine in human skin, Anaesthesia, 62, 146, 10.1111/j.1365-2044.2006.04901.x Shimo, 2005, Two episodes of cardiac arrest in a boy receiving sclerotherapy with polidocanol: a case report, Masui, 54, 57 Bernard, 1991, Reversible cardiac arrest after polidocanol endoscopic sclerotherapy of esophageal varices in infants, Gastroenterol Clin Biol, 15, 456 Paterlini, 1984, Heart failure and endoscopic sclerotherapy of variceal bleeding, Lancet, 1, 1241, 10.1016/S0140-6736(84)91726-4 Marrocco-Trischitta, 2002, Reversible cardiac arrest after polidocanol sclerotherapy of peripheral venous malformation, Dermatol Surg, 28, 153, 10.1046/j.1524-4725.2002.00344.x Paysant, 2006, L’aetoxisclérol accusé à tort d’entraîner une mort subite, Acta Clin Belg, Suppl. 1, 51 Comité de Coordination des vigilances des produits de santé. Bilan 2003 : Principaux faits marquants. Afssaps. 2003. Ceulen, 2008, Microembolism during foam sclerotherapy of varicose veins, N Engl J Med, 358, 1525, 10.1056/NEJMc0707265